Allergan starts work on $200m expansion project in Texas

WCN Editorial Team 27 Apr 2016 NORTH AMERICA BUILDINGS

Pharmaceutical company Allergan has begun work on a $200m expansion of its facility in Waco, Texas.

The Waco facility is the company's flagship manufacturing facility for its eye care products such as Restasis, Lumigan, Combigan, Refresh Plus, Refresh Tears and Latisse.

The project will increase the manufacturing space of the existing facility by 322,000 sq ft, nearly doubling its current footprint.

The expansion will add a new raw material dispensary, an automated bulk formulation suite and ten new production lines, as well as warehousing space.

The Waco facility will be able to manufacture more than 40 different products and its production capacity will be increased by more than 50%.

When completed, the extended capacity will add about 100 full-time jobs, and at full utilization will have the potential to add 250 more.

Allergan’s president and CEO Brent Saunders said: "Today's groundbreaking marks an important milestone for Allergan, strengthening our commitment to our people, operations and the partnership we have built with Waco and the Central Texas communities for 27 years.

"This investment will add highly-skilled jobs to the Waco and Central Texas economies, elevate our manufacturing capabilities and increase our ability to provide more complex medicines to more physicians and their patients around the globe.”

The construction, commissioning and validation of the facility expansion and production processes are scheduled to be completed by 2020. 

With 11 websites and newsletters covering all the key areas within the construction industry, World Construction Industry Network is the leading global construction information resource. READ ABOUT US



World Construction Network | is a product of GlobalData. Copyright © 2022 GlobalData. All rights reserved.